Al-Dawaa Medical Services Company

Equities

4163

SA15H14I11H6

Drug Retailers

Market Closed - Saudi Arabian S.E. 08:20:06 2024-05-16 am EDT 5-day change 1st Jan Change
90.8 SAR -1.63% Intraday chart for Al-Dawaa Medical Services Company -3.40% -14.18%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Aldawaa Medical Services Posts Higher Q1 Net Profit, Revenue MT
Al-Dawaa Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Al-Dawaa Medical Services Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Al-Dawaa Medical Services Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Al-Dawaa Medical Services Company Reports Earnings Results for the Second Quarter Ended June 30, 2023 CI
Al-Dawaa Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Al-Dawaa Medical Services Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Al-Dawaa Medical Services Company Reports Earnings Results for the Third Quarter Ended September 30, 2022 CI
Al-Dawaa Medical Services Company(SASE:4163) added to S&P Global BMI Index CI
Al-Dawaa Medical Services Company(SASE:4163) added to S&P Pan Arab Composite CI
Certain Ordinary Shares of Al-Dawaa Medical Services Company are subject to a Lock-Up Agreement Ending on 7-SEP-2022. CI
Al-Dawaa Medical Services Company Announces the Opening of New Pharmacy CI
Al-Dawaa Medical Services Company has completed an IPO in the amount of SAR 1.8615 billion. CI
Al-Dawaa Medical Services Company has filed an IPO. CI
Aqua Bio Technology Receives Green Light from Al Dawaa Pharmacies CI
Chart Al-Dawaa Medical Services Company
More charts
Al Dawaa Medical Services Company SJSC is a Saudi Arabia- based entity, which is primarily engaged in selling pharmaceutical and healthcare products. The Company is engaged in online wholesale of pharmaceutical products, wholesale of pharmaceutical goods, related pharmacy activities, pharmaceutical warehousing activities, and retail of medical equipment, among others. The Company operates in two segments: Retail, which includes the sale of goods to customers commonly at the store checkout for the sales via the Group's pharmacies; and Wholesale, which includes sale of goods to the wholesale customers. The Company’s products include mum and baby, beauty care, personal care, health and wellness, medicine and treatments, and vitamins and healthy nutrition. The Company operates approximately four subsidiaries.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
90.8 SAR
Average target price
114.2 SAR
Spread / Average Target
+25.74%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4163 Stock
  4. News Al-Dawaa Medical Services Company
  5. Aldawaa Medical Services Posts Higher Q1 Net Profit, Revenue
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW